|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100049860 |
|
最近更新日期: Date of Last Refreshed on: |
2021-08-10 11:44:51 |
|
注册时间: Date of Registration: |
2021-08-10 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
微种植钉辅助Herbst治疗恒牙早期安氏II1下颌后缩高角病例的疗效研究 |
|
Public title: |
Effect of mini-implants assisted Herbst in the treatment of permanent tooth early stage Angle Class II1 malocclusion of high angle mandibular retraction |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
安氏II1高角下颌后缩 |
|
Scientific title: |
Angle Class II1 malocclusion of high angle mandibular retraction |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
徐逸晨 |
研究负责人: |
潘杰 |
|
Applicant: |
Yi-chen Xu |
Study leader: |
Jie Pan |
|
申请注册联系人电话: Applicant telephone: |
18701986794 |
研究负责人电话:
Study leader's |
13917532989 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
783594928@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
68656435@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市黄浦区北京东路356号 |
研究负责人通讯地址: |
上海市黄浦区北京东路356号 |
|
Applicant address: |
356 East Bejing Road, Huangpu District, Shanghai |
Study leader's address: |
356 East Bejing Road, Huangpu District, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海市口腔病防治院 |
||
|
Applicant's institution: |
Shanghai Stomatological Hospital |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
沪口防伦审[2021]012号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市口腔病防治院医学伦理委员会 |
||
|
Name of the ethic committee: |
Ethic committee of Shanghai Stomatological Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-05-16 00:00:00 | ||
|
伦理委员会联系人: |
施培凤 |
||
|
Contact Name of the ethic committee: |
Pei-Feng Shi |
||
|
伦理委员会联系地址: |
上海市黄浦区北京东路356号 |
||
|
Contact Address of the ethic committee: |
356 East Bejing Road, Huangpu District, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
上海市口腔病防治院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Stomatological Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市黄浦区北京东路356号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
356 East Bejing Road, Huangpu District, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
上海市科委“科技创新行动计划”医学创新研究专项 |
||||||||||||||||||||||
|
Source(s) of funding: |
Medical innovation research project of Shanghai Science and Technology Commission |
||||||||||||||||||||||
|
研究疾病: |
安氏II1类错合 |
||||||||||||||||||||||
|
Target disease: |
Angle Class II1 malocclusion |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
研究微种植体联合Herbst治疗恒牙列早期安氏II1高角下颌后缩的疗效 |
||||||||||||||||||||||
|
Objectives of Study: |
To investigate the effect of mini-implants assisted Herbst in the treatment of permanent tooth early stage Angle Class II1 malocclusion of high angle mandibular retraction |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)患者年龄10-13岁,男女不限; (2)为Angle II类1分类错合,患者表现为下颌后缩,上颌正常或轻度前突; (3)ANB≥4°; (4)磨牙远中关系且下颌后退至少半个前磨牙距离,前牙覆盖≥4mm; (5)X线头颅侧位片示:高角(FMA>33°); (6)口腔状况良好(牙周组织健康、无根尖周感染及未充填龋病) |
||||||||||||||||||||||
|
Inclusion criteria |
(1) 10-13 years of age, male or female; (2) Angle Class II1 maloccusion. with presence of mandibular retrusion and normal or mild maxillary protrusion (3)ANB≥4 °; (4) Molar distalization and mandibular recession at least half of the distance of premolars, anterior teeth coverage ≥ 4mm; (5) The lateral cephalogram showed high angle (FMA > 33 ° (6) Oral condition was good (healthy periodontal tissue, no periapical infection and no unfilled caries). |
||||||||||||||||||||||
|
排除标准: |
①排除有颞下颌关节病史、系统疾病史、全身代谢性疾病、服药史; ②排除牙齿移动区域存在骨岛、骨瘤、根尖囊肿、牙根吸收、牙根暴露等情况; ③排除牙周附着丧失、牙槽骨吸收大于10%的牙周炎患者; ④排除牙龈退缩2mm者; ⑤排除精神异常或运动障碍者; ⑥排除骨代谢异常者(包括服用抗骨吸收药物、激素类药物、免疫抑制剂) |
||||||||||||||||||||||
|
Exclusion criteria: |
① Patients with history of temporomandibular joint, systemic diseases, systemic metabolic diseases and medication history; ② Bone island, osteoma, apical cyst, root resorption or root exposure in the orthodontic tooth movement area; ③ Periodontitis patients with periodontal attachment loss and alveolar bone resorption more than 10%; ④ Gingival recession 2mm; ⑤ Mental disorders or dyskinesia; ⑥ The patients with abnormal bone metabolism (including taking anti bone resorption drugs, hormone drugs and immunosuppressants) |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-07-24 00:00:00至 To 2024-12-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2021-08-10 00:00:00 至 To 2024-12-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
简单随机法 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Simple randomization |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
临床试验注册平台 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
www.chictr.org.cn |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
使用病例报告表,数据录入EDC进行数据管理 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data on case report forms will be entered and managed in an EDC system. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |